Home/Filings/4/0001235802-20-000092
4//SEC Filing

Asper Jason D. 4

Accession 0001235802-20-000092

CIK 0001492658other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 4:36 PM ET

Size

5.5 KB

Accession

0001235802-20-000092

Insider Transaction Report

Form 4
Period: 2020-07-23
Asper Jason D.
Sr VP, Strategy & Corp. Dev.
Transactions
  • Award

    Ordinary Shares, par value EUR 0.03 per share

    2020-07-23+18,86340,740 total
Footnotes (2)
  • [F1]These ordinary shares will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. The grant agreement contemplates that the shares will vest pro rata through the closing of the previously announced Stryker transaction, and shares unvested at closing will be cancelled.
  • [F2]Includes 9,655 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 25,787 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001714435

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:36 PM ET
Size
5.5 KB